Top Biotechnology Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
54.32 B
 0.38 
 0.89 
 0.34 
2AMGN Amgen Inc
28.19 B
 0.02 
 1.39 
 0.03 
3GILD Gilead Sciences
27.12 B
(0.06)
 1.83 
(0.11)
4GMAB Genmab AS
16.47 B
(0.11)
 2.10 
(0.23)
5REGN Regeneron Pharmaceuticals
13.12 B
 0.25 
 1.11 
 0.27 
6HLN Haleon Plc
10.86 B
 0.02 
 1.45 
 0.03 
7VRTX Vertex Pharmaceuticals
9.84 B
 0.16 
 2.03 
 0.32 
8BIIB Biogen Inc
9.84 B
(0.05)
 1.70 
(0.08)
9MRNA Moderna
6.75 B
 0.08 
 3.94 
 0.31 
10BNTX BioNTech SE
6.62 B
(0.08)
 2.18 
(0.17)
11GRFS Grifols SA ADR
6.54 B
(0.07)
 5.42 
(0.41)
12INCY Incyte
3.7 B
 0.06 
 2.03 
 0.12 
13EXAS EXACT Sciences
2.5 B
(0.07)
 2.65 
(0.19)
14BGNE BeiGene
2.46 B
(0.03)
 3.30 
(0.10)
15BMRN Biomarin Pharmaceutical
2.42 B
(0.08)
 1.53 
(0.12)
16UTHR United Therapeutics
2.33 B
(0.05)
 1.63 
(0.09)
17NBIX Neurocrine Biosciences
1.89 B
 0.13 
 1.63 
 0.20 
18EXEL Exelixis
1.83 B
(0.01)
 1.74 
(0.02)
19ALNY Alnylam Pharmaceuticals
1.83 B
(0.05)
 2.61 
(0.14)
20ALKS Alkermes Plc
1.66 B
 0.08 
 2.89 
 0.24 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.